News
-
mRNA flu vax promise
Thursday | Nov 20 2025A NEW mRNA-based flu vaccine developed by Pfizer has been found to be 34.5% more effective against influenza-like illness compared to current flu vaccines, according to a new trial published in the New England Journal of Medicine.
-
Ease cramps
Thursday | Nov 20 2025CRAMPEZE contains magnesium and Viburnum opulus (cramp bark) to help relieve night cramps plus mild muscle twitches and spasms.
-
Back the bid
Thursday | Nov 20 2025GLUCOJEL has teamed up with Netball Australia in its bid for the game's inclusion at the Brisbane 2032 Olympics.
-
Blooms hits blister pack milestone
Thursday | Nov 20 2025BLOOMS The Chemist, in partnership with Pharmacycle, has reached a blister pack recycling milestone, doubling the number recycled to 20 million over the past 12 months.
-
CWH, Priceline among most loved retailers
Thursday | Nov 20 2025CHEMIST Warehouse is among Australia's top 10 favourite retailers, according to Power Retail's second annual Most Loved Retailers report.
-
Editor’s Choice: Kadura launches debut botanical haircare collection
Thursday | Nov 20 2025AUSTRALIAN herbal haircare company Kadura Beauty has launched its debut vegan haircare range, formulated with native botanical ingredients like kakadu plum, guarana and lemon peel oil, as well as effective, scientifically backed actives.
-
Skin-friendly cosmetics
Thursday | Nov 20 2025DB COSMETICS has recently launched its Daylight Defence collection, combining sun protection with lightweight textures and glow-boosting formulas.
-
Gentle protection for the whole family
Thursday | Nov 20 2025JUST in time for the Christmas holidays and long summer days, Fend inspect repellent offers the whole family a clinically proven way to keep mosquitoes away for 14 hours as well as provide protection from ticks, wasps, midges and sandflies.
-
Brow perfection kit
Thursday | Nov 20 2025THE 1000 Hour Brow Perfection Kit (RRP $48.96) has all the tools needed to keep brows in place.
-
CSL to expand US operations
Thursday | Nov 20 2025AUSTRALIAN biopharma giant CSL announced yesterday that it plans to expand its US presence over the next five years, with approximately US$1.5 billion (A$2.3 billion) in US capital investments.
